AAAAAA
Results:
1-10
|
Results: 10
Authors:
Heider, A
Niederle, N
Citation: A. Heider et N. Niederle, Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkin's lymphomas, ANTI-CANC D, 12(9), 2001, pp. 725-729
Authors:
Kvasnicka, HM
Thiele, J
Schmitt-Graeff, A
Diehl, V
Zankovich, R
Niederle, N
Leder, LD
Schafer, HE
Citation: Hm. Kvasnicka et al., Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph1+ chronic myelogenous leukemia: A multicenter trial, J CL ONCOL, 19(12), 2001, pp. 2994-3009
Authors:
Kvasnicka, HM
Thiele, J
Schmitt-Graeff, A
Diehl, V
Zankovich, R
Niederle, N
Leder, LD
Schaefer, HE
Citation: Hm. Kvasnicka et al., Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia - a multicentre study on 495 patients, BR J HAEM, 112(3), 2001, pp. 727-739
Authors:
Thiele, J
Kvasnicka, HM
Schmitt-Graeff, A
Diehl, V
Niederle, N
Schaefer, HE
Citation: J. Thiele et al., Bone marrow histopathology predicting blast crisis in chronic myeloid leukemia, ACT HAEMAT, 105(4), 2001, pp. 244-246
Authors:
Thiele, J
Kvasnicka, HM
Schmitt-Graeff, A
Zirbes, TK
Birnbaum, F
Kressmann, C
Melguizo-Grahmann, M
Frackenpohl, H
Sprungmann, C
Leder, LD
Diehl, V
Zankovich, R
Schaefer, HE
Niederle, N
Fischer, R
Citation: J. Thiele et al., Bone marrow features and clinical findings in chronic myeloid leukemia - Acomparative, multicenter, immunohistological and morphometric study on 614patients, LEUK LYMPH, 36(3-4), 2000, pp. 295
Authors:
Kloke, O
Opalka, B
Niederle, N
Citation: O. Kloke et al., Interferon alfa as primary treatment of chronic myeloid leukemia: long-term followup of 71 patients observed in a single center, LEUKEMIA, 14(3), 2000, pp. 389-392
Authors:
Thiele, J
Kvasnicka, HM
Schmitt-Graeff, A
Spohr, M
Diehl, V
Zankovich, R
Niederle, N
Leder, LD
Citation: J. Thiele et al., Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study, BR J HAEM, 108(1), 2000, pp. 64-71
Authors:
Bokemeyer, C
Gerl, A
Schoffski, P
Harstrick, A
Niederle, N
Beyer, J
Casper, J
Schmoll, HJ
Kanz, L
Citation: C. Bokemeyer et al., Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer, J CL ONCOL, 17(2), 1999, pp. 512-516
Authors:
Fossa, A
Santoro, A
Hiddemann, W
Truemper, L
Niederle, N
Buksmaui, S
Bonadonna, G
Seeber, S
Nowrousian, MR
Citation: A. Fossa et al., Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma, J CL ONCOL, 17(12), 1999, pp. 3786-3792
Authors:
Doberauer, C
Niederle, N
Citation: C. Doberauer et N. Niederle, Myeloma-associated amyloidosis of the upper gastrointestinal tract, ONKOLOGIE, 22(6), 1999, pp. 508-511
Risultati:
1-10
|